Search Results

NU 7026 50 mg  | 100.00%

TargetMol

NU7026 is an effective DNA-PK inhibitor (IC50: 0.23 μM, in cell-free assays), 60-fold selective for DNA-PK than PI3K and no inhibition against both ATM and ATR.

More Information Supplier Page

NU 7026 5 mg  | 100.00%

TargetMol

NU7026 is an effective DNA-PK inhibitor (IC50: 0.23 μM, in cell-free assays), 60-fold selective for DNA-PK than PI3K and no inhibition against both ATM and ATR.

More Information Supplier Page

FG-2216 10 mg  | 98.32%

TargetMol

FG-2216 (YM-311) is a potent HIF-prolyl hydroxylase inhibitor for the PDH2 enzyme (IC50: 3.9 uM); orally bioavailable and induced reversible and significant Epo induction in vivo.

More Information Supplier Page

C646 50 mg  | 99.21%

TargetMol

C646, a histone acetyltransferase inhibitor, inhibits p300 (Ki: 400 nM, in a cell-free assay).

More Information Supplier Page

C646 25 mg  | 99.21%

TargetMol

C646, a histone acetyltransferase inhibitor, inhibits p300 (Ki: 400 nM, in a cell-free assay).

More Information Supplier Page

C646 10 mg  | 99.21%

TargetMol

C646, a histone acetyltransferase inhibitor, inhibits p300 (Ki: 400 nM, in a cell-free assay).

More Information Supplier Page

FG-2216 5 mg  | 98.32%

TargetMol

FG-2216 (YM-311) is a potent HIF-prolyl hydroxylase inhibitor for the PDH2 enzyme (IC50: 3.9 uM); orally bioavailable and induced reversible and significant Epo induction in vivo.

More Information Supplier Page

FG-2216 50 mg  | 98.32%

TargetMol

FG-2216 (YM-311) is a potent HIF-prolyl hydroxylase inhibitor for the PDH2 enzyme (IC50: 3.9 uM); orally bioavailable and induced reversible and significant Epo induction in vivo.

More Information Supplier Page

FG-2216 25 mg  | 98.32%

TargetMol

FG-2216 (YM-311) is a potent HIF-prolyl hydroxylase inhibitor for the PDH2 enzyme (IC50: 3.9 uM); orally bioavailable and induced reversible and significant Epo induction in vivo.

More Information Supplier Page